PREDICTION METHOD FOR HETEROTOPIC OSSIFICATION DEVELOPMENT AFTER ENDOPROSTHESIS HIP JOINT REPLACEMENT
FIELD: medicine. ^ SUBSTANCE: invention relates to medicine, particularly orthopedics, and can be applied to prevent heterotopic ossification (HO) development after endoprosthesis hip joint replacement. Method consists in C-reactive protein (CRP) and osteoprotegerine (OPG) levels determination in ve...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | eng ; rus |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | FIELD: medicine. ^ SUBSTANCE: invention relates to medicine, particularly orthopedics, and can be applied to prevent heterotopic ossification (HO) development after endoprosthesis hip joint replacement. Method consists in C-reactive protein (CRP) and osteoprotegerine (OPG) levels determination in venous blood serum on 7th day after the operation. In case if one or both indices are equal or less than: CRP - 12 mg/l, OPG - 4.2 pmol/l, HO development possibility is predicted. Conduction of the method allows HO development prediction after endoprosthesis hip joint replacement in early postoperative period. ^ EFFECT: providing HO development prediction after endoprosthesis hip joint replacement in early postoperative period. ^ 2 tbl, 3 ex |
---|